Unity Diabetes Management System
Device Diabetes
General payments
$43,220
Research payments
$549,642
Through program year 2023, $43,220 in general payments and $549,642 in research payments were reported against Unity Diabetes Management System (Diabetes).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $10,291 | 116 |
| 2023 | Research | $549,642 | 13 |
| 2022 | General | $29,995 | 737 |
| 2021 | General | $2,935 | 93 |
Breakdown
The top 5 of 62 recipients; each share is of general payments naming this product in 2023.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 11 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
946 general · 13 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.